Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Plunges 4%; BSE HEALTHCARE Index Up 1.0%
Thu, 31 Oct 9:36

INDRAPRASTHA MEDICAL Plunges 4%; BSE HEALTHCARE Index Up 1.0%Image source: Sakorn BernardaSv/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has plunged 4% and is presently trading at Rs 414.2.

Meanwhile, the BSE HEALTHCARE index is at 43,546.8 (up 1.0%).

Among the top losers in the BSE HEALTHCARE index today are Biocon (down 2.0%) and ASTRAZENECA PHARMA (down 0.8%).

Cipla (up 8.2%) and POLY MEDICURE (up 3.7%) are among the top gainers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 157.9 to Rs 414.2, registering a gain of Rs 256.4 (up 162.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,385.2 to 43,546.8, registering a gain of 59.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 196.9%), SUVEN PHARMACEUTICALS (up 125.6%) and Glenmark Pharma (up 124.6%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,683.1 (down 0.3%).

The top losers among the BSE Sensex today are Tech Mahindra (down 2.7%) and TCS (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,256.0 (down 0.4%). Tech Mahindra and TCS are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,112.7 to 79,683.1, registering a gain of 15,570.4 points (up 24.3%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 29.1% YoY to Rs 424 million for the quarter ended September 2024, compared to a profit of Rs 329 million a year ago. Net sales rose 10.4% to Rs 3,498 million during the period as against Rs 3,170 million in July-September 2023.

For the year ended March 2024, INDRAPRASTHA MEDICAL reported 43.9% increase in net profit to Rs 1,240 million compared to net profit of Rs 862 million during FY23. Revenue of the company grew 13.3% to Rs 12,447 million during FY24.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 25.7.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Plunges 4%; BSE HEALTHCARE Index Up 1.0%". Click here!